Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
How to sound like an astronaut as you follow the first human moon mission in more than half a century - 2Russian drone slams into block of flats in deadly wave of strikes across Kyiv
- 3The Most Vital Crossroads in Olympic History
- 4Geminid meteors streak under green sky | Space photo of the day for Dec. 19, 2025
- 5WHO issues guidance on GLP-1 drugs for obesity
- Step by step instructions to Boost the Eco-friendliness of Your Smash 1500.
- How HIV/AIDS got its name − the words Americans used for the crisis were steeped in science, stigma and religious language
- In a scientific first, biologists recorded a wild wolf potentially using tools
- South African radio presenter among five charged over Russia recruitment plot
- What loving-kindness meditation is and how to practice it in the new year
- The World's Dazzling Regular Miracles
- Senior's Manual for Obtaining a Hyundai Ioniq EV: Tips
- 6 Famous Urban communities for Shopping on the planet
- Triple polar vortex to plunge central and eastern U.S. into Arctic cold through mid-December
